Good News For India! Number Of Cured COVID-19 Cases Near The 80-Lakh Mark

COVID-19 update: Cured cases in India near the 80-lakh mark

Simren Rodrigues

November 10, 2020

Trending News

3 min


A new milestone has been reached for India as the number of cured COVID-19 cases almost reach the 80-Lakh mark. As per the report, India’s total cases surged to 85,91,731 after 38,074 new infections were reported in a single day. This saw 448 new deaths in 24 hours taking India’s death toll to 1,27,059. On the contrary, the total cured cases stand at 79,59,406 with around 42,033 new discharges in a single day. Currently, there are around 5,05,265 active cases in the country. The Indian Council of Medical Research reported that total samples tested up to November 9 stands at 11,96,15,857.

Take a look at the news video here:

India’s cured COVID-19 cases almost reach the 80-lakh mark

Though the cured cases have almost reached the 80-lakh mark, India cannot let its guard down as winter is soon approaching. Another factor that plays an important role is the air pollution levels of the country. Scientists have estimated that 15% of deaths from COVID-19 was as a result of prolonged exposure to air pollution. According to a report by the Indian Council of Medical Research (ICMR), there appears to be a correlation between air pollution and COVID-19 mortality rates. The Director-General Dr Balram Bhargav also warned that COVID-19 along with air pollution can aggravate respiratory disorders.

Also Read | Too early to say AIIMS on ICMR observation on discontinuing plasma therapy for Covid-19

On Tuesday, the Indian Institute of Science claimed that researchers led by Raghavan Varadarajan are working towards developing effective vaccine strategies against SARS-CoV-2 and HIV. As per the two studies, they reported the design of a heat-tolerant COVID-19 vaccine candidate. It also suggested a rapid method to identify specific regions on the HIV envelope that are generally targeted by antibodies. According to the Bengaluru-based IISc, the studies were published in the Journal of Biological Chemistry and Proceedings of the National Academy of Sciences.

Also Read | Senior Palestinian official Erekat dies of COVID-19

According to the news portal, the COVID-19 vaccine candidate contains Receptor Binding Domain, a part of the spike protein of the novel coronavirus. This is reported to be the region that helps the virus stick to the hosts’ cell. The vaccine is being developed by Mr Varadarajan’s lab in collaboration with Mynvax, a startup co-founded by him. The only way to stay safe and healthy this winter is to follow the protocols and use a mask at all times.

Head over to ZEE5 for all the latest news and updates.

Related Topics

Related News

More Loader